Sanofi (NASDAQ:SNY) Forecasted to Earn Q2 2024 Earnings of $0.91 Per Share

Sanofi (NASDAQ:SNY - Free Report) - Equities research analysts at Leerink Partnrs dropped their Q2 2024 earnings estimates for shares of Sanofi in a report issued on Tuesday, April 16th. Leerink Partnrs analyst D. Risinger now expects that the company will post earnings per share of $0.91 for the quarter, down from their prior estimate of $0.93. The consensus estimate for Sanofi's current full-year earnings is $4.15 per share. Leerink Partnrs also issued estimates for Sanofi's Q3 2024 earnings at $1.30 EPS, Q4 2024 earnings at $0.82 EPS, FY2026 earnings at $4.78 EPS and FY2027 earnings at $5.00 EPS.

Sanofi (NASDAQ:SNY - Get Free Report) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.89 EPS for the quarter, missing analysts' consensus estimates of $0.94 by ($0.05). The business had revenue of $11.76 billion for the quarter, compared to the consensus estimate of $13.02 billion. Sanofi had a return on equity of 27.47% and a net margin of 12.56%.

Several other brokerages also recently issued reports on SNY. TheStreet downgraded shares of Sanofi from a "b" rating to a "c" rating in a report on Friday, February 9th. StockNews.com downgraded shares of Sanofi from a "strong-buy" rating to a "buy" rating in a report on Tuesday, February 27th. Finally, Morgan Stanley began coverage on shares of Sanofi in a report on Tuesday, January 23rd. They set an "equal weight" rating and a $55.00 price target for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $55.00.

Sanofi Price Performance

Shares of NASDAQ:SNY traded up $0.91 during midday trading on Friday, reaching $46.30. 3,272,044 shares of the company's stock were exchanged, compared to its average volume of 1,915,780. Sanofi has a 12 month low of $42.63 and a 12 month high of $57.82. The firm has a market capitalization of $117.12 billion, a PE ratio of 19.62, a price-to-earnings-growth ratio of 1.72 and a beta of 0.61. The company's 50 day simple moving average is $47.52 and its two-hundred day simple moving average is $48.62. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.87 and a current ratio of 1.27.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SNY. Fairfield Bush & CO. acquired a new position in Sanofi during the first quarter valued at approximately $26,000. Bank of New York Mellon Corp lifted its stake in Sanofi by 31.3% in the first quarter. Bank of New York Mellon Corp now owns 440,646 shares of the company's stock valued at $22,623,000 after buying an additional 105,046 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in Sanofi by 12.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 24,613 shares of the company's stock valued at $1,264,000 after buying an additional 2,805 shares in the last quarter. Yousif Capital Management LLC lifted its stake in Sanofi by 45.2% in the first quarter. Yousif Capital Management LLC now owns 42,041 shares of the company's stock valued at $2,158,000 after buying an additional 13,095 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Sanofi by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 300,009 shares of the company's stock valued at $15,402,000 after buying an additional 1,391 shares in the last quarter. Institutional investors and hedge funds own 10.04% of the company's stock.

Sanofi Increases Dividend

The business also recently announced an annual dividend, which will be paid on Thursday, June 6th. Shareholders of record on Friday, May 10th will be paid a $1.478 dividend. The ex-dividend date of this dividend is Thursday, May 9th. This is an increase from Sanofi's previous annual dividend of $1.38. This represents a dividend yield of 2.98%. Sanofi's payout ratio is currently 58.47%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.